| Medical Mutual | Pemetrexed: Alimta® (Intravenous/Intrathecal) (EOV) | 2026-06-01 |
| Medical Mutual | Rituximab: Riabni®, Rituxan®, Ruxience®, Truxima® (Intravenous) (EOV) | 2026-06-01 |
| Medical Mutual | Tecentriq® (atezolizumab) (Intravenous) (EOV) | 2026-06-01 |
| Medical Mutual | Tecvayli® (teclistamab-cqyv) (Subcutaneous) (EOV) | 2026-06-01 |
| Ambetter Health Alabama Clinical | Transcranial Magnetic Stimulation for Treatment Resistant Major Depression | 2026-06-01 |
| BCBS Highmark Delaware | Chimeric Antigen Receptor T-Cell and T-Cell Receptor Therapies | 2026-06-01 |
| Ambetter Health Arizona Clinical | Transcranial Magnetic Stimulation for Treatment Resistant Major Depression | 2026-06-01 |
| BCBS Louisiana | Chelation Therapy | 2026-06-01 |
| BCBS Louisiana | Chronic Intermittent Intravenous Insulin Therapy (CIIIT) | 2026-06-01 |
| BCBS Louisiana | Continuous Passive Motion (CPM) | 2026-06-01 |